Suggestions
Leonard Weisman
President, Chief Technology Officer at Vax-Immune Diagnostics
Professional Background
Leonard (Lenny) Weisman is a visionary leader in the field of medicine and an innovator dedicated to improving diagnoses for infectious diseases. As the founder of Vax-Immune Diagnostics, established in 2011, Lenny has harnessed his extensive experience as a neonatologist to pioneer advanced diagnostic solutions. Having spent an impressive 40 years in the medical field, Lenny witnessed the devastating consequences of misdiagnosis in infants, which fueled his passion for developing innovative technologies to save lives. His groundbreaking product, LabReady®, which features specimen multiplier technology, signifies a pivotal shift in the transportation and handling of medical specimens, thus reducing the risk of misdiagnosis and enhancing patient safety.
Born in a displaced persons camp in Germany to Holocaust survivors, Lenny's inspiring journey began at an early age. His family's history instilled in him a deep commitment to making a difference in the world. Earning a Bachelor of Science in Engineering and Life Sciences from the United States Military Academy at West Point, Lenny epitomized determination and excellence. After completing his education, he ascended through the ranks of the U.S. Army Medical Corps, serving for 24 years. During his military career, he distinguished himself as an academic neonatologist and contributed significant advancements in neonatal care.
after transitioning from military life, Lenny took on pivotal roles in academia, including serving as Chief of the Newborn Service at Texas Children's Hospital, which is renowned as the largest neonatal unit in the United States. His passion for research and education flourished as he joined the faculty at Baylor College of Medicine, where he directed the Neonatal-Perinatal Medicine Fellowship and led various initiatives, including the creation of the Women’s Pavilion.
Education and Achievements
Lenny’s educational journey laid the foundation for his illustrious career in pediatrics and neonatology. He completed his Doctor of Medicine (M.D.) at Baylor College of Medicine, followed by rigorous training at Fitzsimons Army Medical Center, where he achieved board certification in Neonatal-Perinatal Medicine during his fellowship and completed a pediatric residency.
His academic accolades and multiple roles have elevated him as a leading figure in the medical community. He made substantial contributions to the success of Medimmune, where he discovered and helped develop a breakthrough drug that sold to AstraZeneca for an astonishing $15 billion. Not only did Lenny excel in private sector medicine, but he has also played vital roles in shaping future medical professionals as a former Professor of Pediatrics.
One of the highlights of his career was his involvement in the birth and care of the world’s first surviving set of octuplets at Texas Children’s Hospital, which brought him international recognition and featured him in prominent media outlets, including The New York Times, CNN, and the Today Show. These accomplishments showcase Lenny's commitment to advancing medicine and providing exemplary care to infants and families.
Current Endeavors
Currently, Leonard Weisman leads Vax-Immune Diagnostics as its Chief Technology Officer, driving the development of innovative diagnostics to improve healthcare outcomes. The company is at the forefront of transforming how infectious diseases are diagnosed, and Lenny's leadership positions Vax-Immune to bring their first device to market, a significant milestone in medical diagnostics.
Through his work, Lenny continues to inspire a generation of medical professionals and contributes to the field of pediatrics with cutting-edge technologies and practices that enhance care for the most vulnerable populations—newborns. As he moves forward, Lenny’s steadfast vision and dedication to excellence remain a powerful driving force in the healthcare industry.